Skip to main content
Equibles

DIMENSIONAL FUND ADVISORS LP

Position in ZYME — Zymeworks Inc.

CIK 354204 AUSTIN, TX
Back to ZYME Full portfolio

Position in ZYME

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$26,008,122
-$2,515,816 QoQ
Shares Held
994,955
-12.7% QoQ
Ownership
1.40%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 202 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority Sole 90% Shared 6% None 5%

Common Shares in ZYME Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DIMENSIONAL FUND ADVISORS LP holds $6,163,799,259 across 230 Biotechnology names. ZYME ranks #55 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,168,956 $580,655,511
2 JAZZ
Jazz Pharmaceuticals plc
 1,713,592 $412,924,262
3 REGN
Regeneron Pharmaceuticals, Inc.
 559,687 $348,987,230
4 INCY
Incyte Corp
 2,280,803 $258,551,825
5 EXEL
Exelixis, Inc.
 4,426,620 $240,852,392
6 BMRN
Biomarin Pharmaceutical Inc
 4,075,714 $233,212,353
7 ROIV
Roivant Sciences Ltd.
 5,230,417 $185,104,455
8 KRYS
Krystal Biotech, Inc.
 476,038 $176,929,041

All Filings in ZYME

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $26,008,122 994,955
2026-03-31 $28,523,938 1,139,135
2025-12-31 $30,522,128 1,159,215
2025-09-30 $20,339,510 1,190,838
2025-06-30 $14,965,020 1,192,432
2025-03-31 $12,856,343 1,079,458
2024-12-31 $14,240,940 972,742
2024-09-30 $10,661,248 849,502
2024-06-30 $6,090,027 715,632
2024-03-31 $3,309,212 314,564
2023-12-31 $3,555,613 342,215
2023-09-30 $2,213,921 349,199
2023-06-30 $775,810 89,793
2023-03-31 $811,728 89,793